NKTR Deadline: Rosen Law Firm Urges Nektar Therapeutics (NASDAQ: NKTR) Stockholders to Contact the Firm for Information About Their RightsApril 27, 2026
Share Twitter Facebook LinkedIn Email 40 of Bresnahan’s trades, worth at least $166,000, were made after May 6, when he announced that he would move his assets into a blind trust.Read More